Brief: Lineage Cell Therapeutics Says On May 1, Filed A Sales Agreement Prospectus With SEC In Connection With Offer And Sale Of $25 Mln Of ATM Shares
March 5 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS - ON MAY 1, FILED A SALES
AGREEMENT
PROSPECTUS WITH SEC IN CONNECTION WITH OFFER AND SALE OF $25
MILLION OF ATM SHARES
* LINEAGE CELL THERAPEUTICS - HAS SOLD ALL $25 MILLION OF
ATM
SHARES UNDER SALES AGREEMENT PROSPECTUS
Source: [https://bit.ly/3ee8tNG]
Further company coverage: LCTX.A
((reuters.briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million